Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JF.1.1.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HK.11ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
JN.3.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
XDEORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
KE.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HF.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HK.22ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FW.1.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
JN.13ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
KH.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
LM.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.1.17ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.15ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.1.1.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.1.63.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.1.27ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
XDCEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDCNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XDCNCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XDCNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDCNNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FL.15.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.15.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.15.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FL.15.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JR.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JR.1.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JR.1.1.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JR.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
JR.1.1.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JD.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JD.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JD.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JG.3.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JG.3.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JG.3.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JG.3.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JG.3.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
KE.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KE.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KE.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KE.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KE.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HV.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HV.1.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HV.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used